Monitoring end-tidal agent

What it is (and why you care)

• End‑tidal agent (ETA) monitoring measures the concentration of volatile anaesthetic (e.g. sevoflurane, isoflurane, desflurane) in the gas at the end of expiration.
• End‑tidal values reflect alveolar concentration and are a useful proxy for brain partial pressure (i.e. anaesthetic effect), especially once things are stable.
• It helps you confirm the agent is actually being delivered (and not just dialled on the vaporiser).
• It supports safe titration: you can trend changes and avoid accidental awareness or excessive depth (particularly when combined with clinical signs and haemodynamics).
• It can reveal circuit problems (leaks, disconnections, exhausted agent, wrong agent, sampling issues) early.

Key definitions (simple and exam-friendly)

• Inspired agent (FiAgent): concentration measured during inspiration, reflects what is being delivered to the patient.
• End‑tidal agent (EtAgent): concentration measured at end-expiration, reflects what is coming back from the lungs.
• MAC (minimum alveolar concentration): alveolar concentration preventing movement in response to surgical stimulus in 50% of patients, varies with age and other factors.
• MAC fraction: EtAgent expressed as a fraction of MAC for that agent (many monitors display age-adjusted MAC).
• Wash-in: rise in inspired and end‑tidal agent after turning on vapour, wash-out: fall after turning off vapour.

How the monitor measures it (what can go wrong)

• Most theatres use a side‑stream analyser: it continuously samples gas from the breathing circuit via a thin sampling line to the monitor.
• It identifies and quantifies gases (volatile agent, CO2, often N2O) using infrared absorption, the monitor may also display the agent name.
• Sampling line issues are common: kinks, disconnection, water blockage, or being connected to the wrong port can give absent/erratic readings.
• Water traps/filters protect the analyser, if full or missing, readings can fail or become unreliable.
• If the sampling port is too close to fresh gas flow, inspired readings may be falsely high, end‑tidal values are generally more clinically useful.

What patterns to expect in routine cases

• After induction and turning on vapour: FiAgent rises first, EtAgent lags behind and then catches up as the lungs and blood equilibrate.
• During steady state: FiAgent and EtAgent become closer (small gap). A large persistent gap suggests high uptake, leaks, or delivery problems.
• When you increase the vaporiser setting: FiAgent rises quickly, EtAgent rises more slowly over minutes.
• When you turn vapour off: FiAgent falls quickly, EtAgent falls more slowly (wash-out), especially after long cases or with high fat solubility agents.

Practical use for new starters (safe day-to-day approach)

• Always check the monitor is identifying the correct agent (e.g. sevo vs iso) and that values change appropriately when you adjust the vaporiser.
• Use trends: a falling EtAgent may explain rising heart rate/BP or movement, a rising EtAgent may explain hypotension/bradycardia.
• In the first 10–15 minutes, expect EtAgent to be lower than inspired, avoid overreacting to early low EtAgent if the trend is rising and the patient is stable.
• If using low flows, changes in FiAgent/EtAgent are slower, plan ahead when anticipating stimulation (e.g. incision).
• If you are using total intravenous anaesthesia (TIVA), EtAgent should be zero, a non‑zero reading suggests contamination or a vaporiser left on.
• Document agent and typical EtAgent/MAC fraction during maintenance, it helps handover and troubleshooting.

First-time scenarios and what to do

• EtAgent reads zero despite vaporiser on: check vaporiser is seated/locked, turned on, filled, check fresh gas flow, check sampling line connection and water trap, look for circuit leak/disconnection, confirm you are ventilating the patient.
• Sudden drop in EtAgent and EtCO2 together: think disconnection, major leak, or sampling line off, check patient and circuit immediately.
• EtAgent unexpectedly high with hypotension: reduce vaporiser, increase fresh gas flow temporarily to wash out, support BP (fluids/vasopressor as appropriate), and reassess.
• Agent name on monitor changes unexpectedly: consider cross-contamination, wrong agent in vaporiser (rare but serious), or analyser error, stop and verify vaporiser contents/labels and consider changing to a known safe plan.
• During emergence: expect EtAgent to fall, if it stays high, check you have actually turned vapour off and consider low ventilation, low fresh gas flow, or rebreathing.

Linking EtAgent to depth of anaesthesia (keep it simple and safe)

• EtAgent is one input into depth assessment, always interpret alongside clinical signs, haemodynamics, analgesia, neuromuscular blockade, and surgical stimulation.
• MAC is a population measure, individuals vary. Elderly patients generally need less, young adults more.
• Nitrous oxide reduces the amount of volatile needed (MAC-sparing). Opioids and other sedatives also reduce requirements.
• Avoid relying on a single number: use trends and the whole clinical picture, especially during rapid changes (induction, incision, emergence).

Test yourself…